Your browser doesn't support javascript.
loading
Accelerated dual-venc 4D flow MRI with variable high-venc spatial resolution for neurovascular applications.
Aristova, Maria; Pang, Jianing; Ma, Yue; Ma, Liliana; Berhane, Haben; Rayz, Vitaliy; Markl, Michael; Schnell, Susanne.
Afiliação
  • Aristova M; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Pang J; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Ma Y; MR R&D and Collaborations, Siemens Medical Solutions USA Inc., Chicago, IL, USA.
  • Ma L; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Berhane H; Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Rayz V; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Markl M; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Schnell S; Department of Biomedical Engineering, Northwestern University McCormick School of Engineering, Evanston, Illinois, USA.
Magn Reson Med ; 88(4): 1643-1658, 2022 10.
Article em En | MEDLINE | ID: mdl-35754143
ABSTRACT

PURPOSE:

Dual-velocity encoded (dual-venc or DV) 4D flow MRI achieves wide velocity dynamic range and velocity-to-noise ratio (VNR), enabling accurate neurovascular flow characterization. To reduce scan time, we present interleaved dual-venc 4D Flow with independently prescribed, prospectively undersampled spatial resolution of the high-venc (HV) acquisition Variable Spatial Resolution Dual Venc (VSRDV).

METHODS:

A prototype VSRDV sequence was developed based on a Cartesian acquisition with eight-point phase encoding, combining PEAK-GRAPPA acceleration with zero-filling in phase and partition directions for HV. The VSRDV approach was optimized by varying z, the zero-filling fraction of HV relative to low-venc, between 0%-80% in vitro (realistic neurovascular model with pulsatile flow) and in vivo (n = 10 volunteers). Antialiasing precision, mean and peak velocity quantification accuracy, and test-retest reproducibility were assessed relative to reference images with equal-resolution HV and low venc (z = 0%).

RESULTS:

In vitro results for all z demonstrated an antialiasing true positive rate at least 95% for RPEAK-GRAPPA$$ {R}_{\mathrm{PEAK}-\mathrm{GRAPPA}} $$  = 2 and 5, with no linear relationship to z (p = 0.62 and 0.13, respectively). Bland-Altman analysis for z = 20%, 40%, 60%, or 80% versus z = 0% in vitro and in vivo demonstrated no bias >1% of venc in mean or peak velocity values at any RZF$$ {R}_{\mathrm{ZF}} $$ . In vitro mean and peak velocity, and in vivo peak velocity, had limits of agreement within 15%.

CONCLUSION:

VSRDV allows up to 34.8% scan time reduction compared to PEAK-GRAPPA accelerated DV 4D Flow MRI, enabling large spatial coverage and dynamic range while maintaining VNR and velocity measurement accuracy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Imageamento Tridimensional Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Imageamento Tridimensional Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article